1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,214 | 0,238 | 31.07. | |
| 0,216 | 0,234 | 31.07. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.07. | Brii Biosciences and Joincare sign licence agreement for BRII-693 | 1 | Pharmaceutical Technology | ||
| 04.07. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT LICENSE AGREEMENT WITH JOINCARE | 2 | HKEx | ||
| 03.06. | BRII-B (02137): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 03.06. | BRII-B (02137): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 3, 2025 AND CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE | 1 | HKEx | ||
| BRII BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 08.05. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE | 1 | HKEx | ||
| 28.04. | BRII-B (02137): CLARIFICATION ANNOUNCEMENT (1) CHANGE OF DATE OF ANNUAL GENERAL MEETING; AND (2) CHANGE OF CLOSURE OF THE REGISTER OF MEMBERS | 1 | HKEx | ||
| 25.04. | BRII-B (02137): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| 25.04. | BRII-B (02137): NOTIFICATION LETTER AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS | - | HKEx | ||
| 25.04. | BRII-B (02137): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 25.04. | BRII-B (02137): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING | - | HKEx | ||
| 25.04. | BRII-B (02137): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 25.04. | BRII-B (02137): (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT ... | - | HKEx | ||
| 25.04. | BRII-B (02137): 2024 ANNUAL REPORT | - | HKEx | ||
| 07.04. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 30.03. | Brii Biosciences Limited: Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179's Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification | 68 | PR Newswire | Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to utilize BRII-179 to identify patients who are immune responders and... ► Artikel lesen | |
| 21.03. | Brii Biosciences Limited: Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results | 241 | PR Newswire | Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure
Data... ► Artikel lesen | |
| 21.03. | BRII-B (02137): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 AND CHANGE IN USE OF PROCEEDS | 1 | HKEx | ||
| 21.03. | BRII-B (02137): NOTIFICATION OF 2024 PFIC STATUS | - | HKEx | ||
| 10.03. | BRII-B (02137): DATE OF BOARD MEETING | - | HKEx | ||
| 31.12.24 | Brii Biosciences Limited: Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study | 194 | PR Newswire | Further secures Brii's rights in BRII-179 with full control of intellectual property, future manufacturing and supply
Several combination treatment studies containing... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIOGEN | 111,35 | -0,76 % | Biogen Q2 Results Top Estimates; Boosts FY25 Outlook | WESTON (dpa-AFX) - Biotechnology company Biogen, Inc. (BIIB) reported Thursday that net income attributable to the company for the second quarter grew to $634.8 million or $4.33 per share from... ► Artikel lesen | |
| ILLUMINA | 89,65 | -0,47 % | Illumina: A 5.2 Rating Amid Challenges and Opportunities | ||
| NANOREPRO | 1,600 | +1,27 % | NanoRepro: Gute Kombination | Als NanoRepro im Oktober 2008 an die Börse ging, war der Namenszusatz "Nano" mächtig angesagt. Immerhin starteten zwischen 2005 und 2026 auch die Kapitalmarktstorys von NanoFocus, Nanostart, Nanogate... ► Artikel lesen | |
| BRAIN BIOTECH | 2,210 | -0,45 % | EQS-News: BRAIN Biotech AG: Erfahrene Biotechnologie-Expertin neu im Aufsichtsrat der BRAIN Biotech AG | EQS-News: BRAIN Biotech AG
/ Schlagwort(e): Personalie
Erfahrene Biotechnologie-Expertin neu im Aufsichtsrat der BRAIN Biotech AG
23.07.2025 / 08:30 CET/CEST
Für den... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,439 | +1,62 % | BioTech wird zu Gold: Wer schluckt wen oder was? Auf der Liste sind Evotec, BioNxt, Valneva und Formycon! | Der BioTech-Sektor blickt mit Argusaugen auf das Zinsniveau der Notenbanken. Aktuell allerdings scheint die Inflation noch etwas zu hoch, um massive Senkungen zu erwarten. So hat auch die EZB gestern... ► Artikel lesen | |
| INFLARX | 0,780 | +0,65 % | InflaRx N.V.: InflaRx to Report Second Quarter 2025 Results on August 7, 2025 | ||
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem gibt Finanzierung mittels Wandelschuldverschreibung bekannt | Vancouver, British Columbia, 22. April 2025 / IRW-Press / Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (OTC: SRBCF) ("Sirona" oder das "Unternehmen") gibt eine nicht vermittelte Privatplatzierung... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,380 | -1,30 % | Defence Therapeutics Inc.: Defence's Accum Technology with ADC and Radiopharmaceutical Programs Target Cancer | Montreal, Quebec--(Newsfile Corp. - July 14, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug... ► Artikel lesen | |
| TREVENA | 0,153 | 0,00 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
| BURCON NUTRASCIENCE | 1,840 | +1,66 % | Burcon NutraScience Corporation: Burcon Announces Fiscal 2026 First Quarter Conference Call and Presentation to Be Held on August 13, 2025 | Vancouver, British Columbia--(Newsfile Corp. - July 30, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein... ► Artikel lesen | |
| TME PHARMA | 0,111 | 0,00 % | TME Pharma N.V.: TME Pharma Provides Update About Additional Strategy | Regulatory News:
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for cancer and eye diseases, is pleased... ► Artikel lesen | |
| CYTODYN | 0,228 | +4,59 % | CytoDyn files $100M mixed securities shelf | ||
| IMMUNIC | 0,854 | +3,39 % | EQS-News: Immunic AG: Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis | Issuer: Immunic AG
/ Key word(s): Study/Study results
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in... ► Artikel lesen | |
| PHIO PHARMACEUTICALS | 2,380 | 0,00 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds | King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary... ► Artikel lesen | |
| IOVANCE BIOTHERAPEUTICS | 2,229 | -0,82 % | Is Iovance Biotherapeutics Stock Due for a Big Rally? |
Das Unternehmen BRII BIOSCIENCES LTD kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,218 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRII BIOSCIENCES LTD finden Sie auf Wallstreet Online.